Global Influenza Vaccines Market Insights and Forecast to 2026

Global Influenza Vaccines Market Insights and Forecast to 2026

Table of Contents
1 Study Coverage
1.1 Influenza Vaccines Product Introduction
1.2 Market Segments
1.3 Key Influenza Vaccines Manufacturers Covered: Ranking by Revenue
1.4 Market by Type
1.4.1 Global Influenza Vaccines Market Size Growth Rate by Type
1.4.2 Trivalent Flu Vaccines
1.4.3 Quadrivalent Flu Vaccines
1.5 Market by Application
1.5.1 Global Influenza Vaccines Market Size Growth Rate by Application
1.5.2 Adults
1.5.3 Pediatrics
1.6 Study Objectives
1.7 Years Considered
2 Executive Summary
2.1 Global Influenza Vaccines Market Size, Estimates and Forecasts
2.1.1 Global Influenza Vaccines Revenue 2015-2026
2.1.2 Global Influenza Vaccines Sales 2015-2026
2.2 Global Influenza Vaccines, Market Size by Producing Regions: 2015 VS 2020 VS 2026
2.2.1 Global Influenza Vaccines Retrospective Market Scenario in Sales by Region: 2015-2020
2.2.2 Global Influenza Vaccines Retrospective Market Scenario in Revenue by Region: 2015-2020
3 Global Influenza Vaccines Competitor Landscape by Players
3.1 Influenza Vaccines Sales by Manufacturers
3.1.1 Influenza Vaccines Sales by Manufacturers (2015-2020)
3.1.2 Influenza Vaccines Sales Market Share by Manufacturers (2015-2020)
3.2 Influenza Vaccines Revenue by Manufacturers
3.2.1 Influenza Vaccines Revenue by Manufacturers (2015-2020)
3.2.2 Influenza Vaccines Revenue Share by Manufacturers (2015-2020)
3.2.3 Global Influenza Vaccines Market Concentration Ratio (CR5 and HHI) (2015-2020)
3.2.4 Global Top 10 and Top 5 Companies by Influenza Vaccines Revenue in 2019
3.2.5 Global Influenza Vaccines Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Influenza Vaccines Price by Manufacturers
3.4 Influenza Vaccines Manufacturing Base Distribution, Product Types
3.4.1 Influenza Vaccines Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers Influenza Vaccines Product Type
3.4.3 Date of International Manufacturers Enter into Influenza Vaccines Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Market Size by Type (2015-2026)
4.1 Global Influenza Vaccines Market Size by Type (2015-2020)
4.1.1 Global Influenza Vaccines Sales by Type (2015-2020)
4.1.2 Global Influenza Vaccines Revenue by Type (2015-2020)
4.1.3 Influenza Vaccines Average Selling Price (ASP) by Type (2015-2026)
4.2 Global Influenza Vaccines Market Size Forecast by Type (2021-2026)
4.2.1 Global Influenza Vaccines Sales Forecast by Type (2021-2026)
4.2.2 Global Influenza Vaccines Revenue Forecast by Type (2021-2026)
4.2.3 Influenza Vaccines Average Selling Price (ASP) Forecast by Type (2021-2026)
4.3 Global Influenza Vaccines Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End
5 Market Size by Application (2015-2026)
5.1 Global Influenza Vaccines Market Size by Application (2015-2020)
5.1.1 Global Influenza Vaccines Sales by Application (2015-2020)
5.1.2 Global Influenza Vaccines Revenue by Application (2015-2020)
5.1.3 Influenza Vaccines Price by Application (2015-2020)
5.2 Influenza Vaccines Market Size Forecast by Application (2021-2026)
5.2.1 Global Influenza Vaccines Sales Forecast by Application (2021-2026)
5.2.2 Global Influenza Vaccines Revenue Forecast by Application (2021-2026)
5.2.3 Global Influenza Vaccines Price Forecast by Application (2021-2026)
6 North America
6.1 North America Influenza Vaccines by Country
6.1.1 North America Influenza Vaccines Sales by Country
6.1.2 North America Influenza Vaccines Revenue by Country
6.1.3 U.S.
6.1.4 Canada
6.2 North America Influenza Vaccines Market Facts & Figures by Type
6.3 North America Influenza Vaccines Market Facts & Figures by Application
7 Europe
7.1 Europe Influenza Vaccines by Country
7.1.1 Europe Influenza Vaccines Sales by Country
7.1.2 Europe Influenza Vaccines Revenue by Country
7.1.3 Germany
7.1.4 France
7.1.5 U.K.
7.1.6 Italy
7.1.7 Russia
7.2 Europe Influenza Vaccines Market Facts & Figures by Type
7.3 Europe Influenza Vaccines Market Facts & Figures by Application
8 Asia Pacific
8.1 Asia Pacific Influenza Vaccines by Region
8.1.1 Asia Pacific Influenza Vaccines Sales by Region
8.1.2 Asia Pacific Influenza Vaccines Revenue by Region
8.1.3 China
8.1.4 Japan
8.1.5 South Korea
8.1.6 India
8.1.7 Australia
8.1.8 Taiwan
8.1.9 Indonesia
8.1.10 Thailand
8.1.11 Malaysia
8.1.12 Philippines
8.1.13 Vietnam
8.2 Asia Pacific Influenza Vaccines Market Facts & Figures by Type
8.3 Asia Pacific Influenza Vaccines Market Facts & Figures by Application
9 Latin America
9.1 Latin America Influenza Vaccines by Country
9.1.1 Latin America Influenza Vaccines Sales by Country
9.1.2 Latin America Influenza Vaccines Revenue by Country
9.1.3 Mexico
9.1.4 Brazil
9.1.5 Argentina
9.2 Central & South America Influenza Vaccines Market Facts & Figures by Type
9.3 Central & South America Influenza Vaccines Market Facts & Figures by Application
10 Middle East and Africa
10.1 Middle East and Africa Influenza Vaccines by Country
10.1.1 Middle East and Africa Influenza Vaccines Sales by Country
10.1.2 Middle East and Africa Influenza Vaccines Revenue by Country
10.1.3 Turkey
10.1.4 Saudi Arabia
10.1.5 U.A.E
10.2 Middle East and Africa Influenza Vaccines Market Facts & Figures by Type
10.3 Middle East and Africa Influenza Vaccines Market Facts & Figures by Application
11 Company Profiles
11.1 AstraZeneca
11.1.1 AstraZeneca Corporation Information
11.1.2 AstraZeneca Description and Business Overview
11.1.3 AstraZeneca Sales, Revenue and Gross Margin (2015-2020)
11.1.4 AstraZeneca Influenza Vaccines Products Offered
11.1.5 AstraZeneca Related Developments
11.2 CSL
11.2.1 CSL Corporation Information
11.2.2 CSL Description and Business Overview
11.2.3 CSL Sales, Revenue and Gross Margin (2015-2020)
11.2.4 CSL Influenza Vaccines Products Offered
11.2.5 CSL Related Developments
11.3 GlaxoSmithKline
11.3.1 GlaxoSmithKline Corporation Information
11.3.2 GlaxoSmithKline Description and Business Overview
11.3.3 GlaxoSmithKline Sales, Revenue and Gross Margin (2015-2020)
11.3.4 GlaxoSmithKline Influenza Vaccines Products Offered
11.3.5 GlaxoSmithKline Related Developments
11.4 Sanofi
11.4.1 Sanofi Corporation Information
11.4.2 Sanofi Description and Business Overview
11.4.3 Sanofi Sales, Revenue and Gross Margin (2015-2020)
11.4.4 Sanofi Influenza Vaccines Products Offered
11.4.5 Sanofi Related Developments
11.5 Altimmune
11.5.1 Altimmune Corporation Information
11.5.2 Altimmune Description and Business Overview
11.5.3 Altimmune Sales, Revenue and Gross Margin (2015-2020)
11.5.4 Altimmune Influenza Vaccines Products Offered
11.5.5 Altimmune Related Developments
11.6 BionVax
11.6.1 BionVax Corporation Information
11.6.2 BionVax Description and Business Overview
11.6.3 BionVax Sales, Revenue and Gross Margin (2015-2020)
11.6.4 BionVax Influenza Vaccines Products Offered
11.6.5 BionVax Related Developments
11.7 FluGen
11.7.1 FluGen Corporation Information
11.7.2 FluGen Description and Business Overview
11.7.3 FluGen Sales, Revenue and Gross Margin (2015-2020)
11.7.4 FluGen Influenza Vaccines Products Offered
11.7.5 FluGen Related Developments
11.8 FOLIA BIOTECH
11.8.1 FOLIA BIOTECH Corporation Information
11.8.2 FOLIA BIOTECH Description and Business Overview
11.8.3 FOLIA BIOTECH Sales, Revenue and Gross Margin (2015-2020)
11.8.4 FOLIA BIOTECH Influenza Vaccines Products Offered
11.8.5 FOLIA BIOTECH Related Developments
11.9 Genentech
11.9.1 Genentech Corporation Information
11.9.2 Genentech Description and Business Overview
11.9.3 Genentech Sales, Revenue and Gross Margin (2015-2020)
11.9.4 Genentech Influenza Vaccines Products Offered
11.9.5 Genentech Related Developments
11.10 Green Cross
11.10.1 Green Cross Corporation Information
11.10.2 Green Cross Description and Business Overview
11.10.3 Green Cross Sales, Revenue and Gross Margin (2015-2020)
11.10.4 Green Cross Influenza Vaccines Products Offered
11.10.5 Green Cross Related Developments
11.1 AstraZeneca
11.1.1 AstraZeneca Corporation Information
11.1.2 AstraZeneca Description and Business Overview
11.1.3 AstraZeneca Sales, Revenue and Gross Margin (2015-2020)
11.1.4 AstraZeneca Influenza Vaccines Products Offered
11.1.5 AstraZeneca Related Developments
11.12 Moderna Therapeutics
11.12.1 Moderna Therapeutics Corporation Information
11.12.2 Moderna Therapeutics Description and Business Overview
11.12.3 Moderna Therapeutics Sales, Revenue and Gross Margin (2015-2020)
11.12.4 Moderna Therapeutics Products Offered
11.12.5 Moderna Therapeutics Related Developments
11.13 Novavax
11.13.1 Novavax Corporation Information
11.13.2 Novavax Description and Business Overview
11.13.3 Novavax Sales, Revenue and Gross Margin (2015-2020)
11.13.4 Novavax Products Offered
11.13.5 Novavax Related Developments
11.14 Shijiazhuang Yiling Pharmaceutical
11.14.1 Shijiazhuang Yiling Pharmaceutical Corporation Information
11.14.2 Shijiazhuang Yiling Pharmaceutical Description and Business Overview
11.14.3 Shijiazhuang Yiling Pharmaceutical Sales, Revenue and Gross Margin (2015-2020)
11.14.4 Shijiazhuang Yiling Pharmaceutical Products Offered
11.14.5 Shijiazhuang Yiling Pharmaceutical Related Developments
11.15 SK Chemicals
11.15.1 SK Chemicals Corporation Information
11.15.2 SK Chemicals Description and Business Overview
11.15.3 SK Chemicals Sales, Revenue and Gross Margin (2015-2020)
11.15.4 SK Chemicals Products Offered
11.15.5 SK Chemicals Related Developments
11.16 UNM Pharma
11.16.1 UNM Pharma Corporation Information
11.16.2 UNM Pharma Description and Business Overview
11.16.3 UNM Pharma Sales, Revenue and Gross Margin (2015-2020)
11.16.4 UNM Pharma Products Offered
11.16.5 UNM Pharma Related Developments
11.17 Vaccitech
11.17.1 Vaccitech Corporation Information
11.17.2 Vaccitech Description and Business Overview
11.17.3 Vaccitech Sales, Revenue and Gross Margin (2015-2020)
11.17.4 Vaccitech Products Offered
11.17.5 Vaccitech Related Developments
11.18 Vaxart
11.18.1 Vaxart Corporation Information
11.18.2 Vaxart Description and Business Overview
11.18.3 Vaxart Sales, Revenue and Gross Margin (2015-2020)
11.18.4 Vaxart Products Offered
11.18.5 Vaxart Related Developments
11.19 Vaxine Pty
11.19.1 Vaxine Pty Corporation Information
11.19.2 Vaxine Pty Description and Business Overview
11.19.3 Vaxine Pty Sales, Revenue and Gross Margin (2015-2020)
11.19.4 Vaxine Pty Products Offered
11.19.5 Vaxine Pty Related Developments
11.20 Visterra
11.20.1 Visterra Corporation Information
11.20.2 Visterra Description and Business Overview
11.20.3 Visterra Sales, Revenue and Gross Margin (2015-2020)
11.20.4 Visterra Products Offered
11.20.5 Visterra Related Developments
12 Future Forecast by Regions (Countries) (2021-2026)
12.1 Influenza Vaccines Market Estimates and Projections by Region
12.1.1 Global Influenza Vaccines Sales Forecast by Regions 2021-2026
12.1.2 Global Influenza Vaccines Revenue Forecast by Regions 2021-2026
12.2 North America Influenza Vaccines Market Size Forecast (2021-2026)
12.2.1 North America: Influenza Vaccines Sales Forecast (2021-2026)
12.2.2 North America: Influenza Vaccines Revenue Forecast (2021-2026)
12.2.3 North America: Influenza Vaccines Market Size Forecast by Country (2021-2026)
12.3 Europe Influenza Vaccines Market Size Forecast (2021-2026)
12.3.1 Europe: Influenza Vaccines Sales Forecast (2021-2026)
12.3.2 Europe: Influenza Vaccines Revenue Forecast (2021-2026)
12.3.3 Europe: Influenza Vaccines Market Size Forecast by Country (2021-2026)
12.4 Asia Pacific Influenza Vaccines Market Size Forecast (2021-2026)
12.4.1 Asia Pacific: Influenza Vaccines Sales Forecast (2021-2026)
12.4.2 Asia Pacific: Influenza Vaccines Revenue Forecast (2021-2026)
12.4.3 Asia Pacific: Influenza Vaccines Market Size Forecast by Region (2021-2026)
12.5 Latin America Influenza Vaccines Market Size Forecast (2021-2026)
12.5.1 Latin America: Influenza Vaccines Sales Forecast (2021-2026)
12.5.2 Latin America: Influenza Vaccines Revenue Forecast (2021-2026)
12.5.3 Latin America: Influenza Vaccines Market Size Forecast by Country (2021-2026)
12.6 Middle East and Africa Influenza Vaccines Market Size Forecast (2021-2026)
12.6.1 Middle East and Africa: Influenza Vaccines Sales Forecast (2021-2026)
12.6.2 Middle East and Africa: Influenza Vaccines Revenue Forecast (2021-2026)
12.6.3 Middle East and Africa: Influenza Vaccines Market Size Forecast by Country (2021-2026)
13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
13.1 Market Opportunities and Drivers
13.2 Market Challenges
13.3 Market Risks/Restraints
13.4 Porter's Five Forces Analysis
13.5 Primary Interviews with Key Influenza Vaccines Players (Opinion Leaders)
14 Value Chain and Sales Channels Analysis
14.1 Value Chain Analysis
14.2 Influenza Vaccines Customers
14.3 Sales Channels Analysis
14.3.1 Sales Channels
14.3.2 Distributors
15 Research Findings and Conclusion
16 Appendix
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
16.3 Disclaimer
List of Tables
Table 1. Influenza Vaccines Market Segments
Table 2. Ranking of Global Top Influenza Vaccines Manufacturers by Revenue (US$ Million) in 2019
Table 3. Global Influenza Vaccines Market Size Growth Rate by Type 2020-2026 (K Units) & (US$ Million)
Table 4. Major Manufacturers of Trivalent Flu Vaccines
Table 5. Major Manufacturers of Quadrivalent Flu Vaccines
Table 6. Global Influenza Vaccines Market Size Growth Rate by Application 2020-2026 (K Units)
Table 7. Global Influenza Vaccines Market Size by Region (K Units) & (US$ Million): 2020 VS 2026
Table 8. Global Influenza Vaccines Sales by Regions 2015-2020 (K Units)
Table 9. Global Influenza Vaccines Sales Market Share by Regions (2015-2020)
Table 10. Global Influenza Vaccines Revenue by Regions 2015-2020 (US$ Million)
Table 11. Global Influenza Vaccines Sales by Manufacturers (2015-2020) (K Units)
Table 12. Global Influenza Vaccines Sales Share by Manufacturers (2015-2020)
Table 13. Global Influenza Vaccines Manufacturers Market Concentration Ratio (CR5 and HHI) (2015-2020)
Table 14. Global Influenza Vaccines by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Influenza Vaccines as of 2019)
Table 15. Influenza Vaccines Revenue by Manufacturers (2015-2020) (US$ Million)
Table 16. Influenza Vaccines Revenue Share by Manufacturers (2015-2020)
Table 17. Key Manufacturers Influenza Vaccines Price (2015-2020) (USD/Unit)
Table 18. Influenza Vaccines Manufacturers Manufacturing Base Distribution and Headquarters
Table 19. Manufacturers Influenza Vaccines Product Type
Table 20. Date of International Manufacturers Enter into Influenza Vaccines Market
Table 21. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 22. Global Influenza Vaccines Sales by Type (2015-2020) (K Units)
Table 23. Global Influenza Vaccines Sales Share by Type (2015-2020)
Table 24. Global Influenza Vaccines Revenue by Type (2015-2020) (US$ Million)
Table 25. Global Influenza Vaccines Revenue Share by Type (2015-2020)
Table 26. Influenza Vaccines Average Selling Price (ASP) by Type 2015-2020 (USD/Unit)
Table 27. Global Influenza Vaccines Sales by Application (2015-2020) (K Units)
Table 28. Global Influenza Vaccines Sales Share by Application (2015-2020)
Table 29. North America Influenza Vaccines Sales by Country (2015-2020) (K Units)
Table 30. North America Influenza Vaccines Sales Market Share by Country (2015-2020)
Table 31. North America Influenza Vaccines Revenue by Country (2015-2020) (US$ Million)
Table 32. North America Influenza Vaccines Revenue Market Share by Country (2015-2020)
Table 33. North America Influenza Vaccines Sales by Type (2015-2020) (K Units)
Table 34. North America Influenza Vaccines Sales Market Share by Type (2015-2020)
Table 35. North America Influenza Vaccines Sales by Application (2015-2020) (K Units)
Table 36. North America Influenza Vaccines Sales Market Share by Application (2015-2020)
Table 37. Europe Influenza Vaccines Sales by Country (2015-2020) (K Units)
Table 38. Europe Influenza Vaccines Sales Market Share by Country (2015-2020)
Table 39. Europe Influenza Vaccines Revenue by Country (2015-2020) (US$ Million)
Table 40. Europe Influenza Vaccines Revenue Market Share by Country (2015-2020)
Table 41. Europe Influenza Vaccines Sales by Type (2015-2020) (K Units)
Table 42. Europe Influenza Vaccines Sales Market Share by Type (2015-2020)
Table 43. Europe Influenza Vaccines Sales by Application (2015-2020) (K Units)
Table 44. Europe Influenza Vaccines Sales Market Share by Application (2015-2020)
Table 45. Asia Pacific Influenza Vaccines Sales by Region (2015-2020) (K Units)
Table 46. Asia Pacific Influenza Vaccines Sales Market Share by Region (2015-2020)
Table 47. Asia Pacific Influenza Vaccines Revenue by Region (2015-2020) (US$ Million)
Table 48. Asia Pacific Influenza Vaccines Revenue Market Share by Region (2015-2020)
Table 49. Asia Pacific Influenza Vaccines Sales by Type (2015-2020) (K Units)
Table 50. Asia Pacific Influenza Vaccines Sales Market Share by Type (2015-2020)
Table 51. Asia Pacific Influenza Vaccines Sales by Application (2015-2020) (K Units)
Table 52. Asia Pacific Influenza Vaccines Sales Market Share by Application (2015-2020)
Table 53. Latin America Influenza Vaccines Sales by Country (2015-2020) (K Units)
Table 54. Latin America Influenza Vaccines Sales Market Share by Country (2015-2020)
Table 55. Latin Americaa Influenza Vaccines Revenue by Country (2015-2020) (US$ Million)
Table 56. Latin America Influenza Vaccines Revenue Market Share by Country (2015-2020)
Table 57. Latin America Influenza Vaccines Sales by Type (2015-2020) (K Units)
Table 58. Latin America Influenza Vaccines Sales Market Share by Type (2015-2020)
Table 59. Latin America Influenza Vaccines Sales by Application (2015-2020) (K Units)
Table 60. Latin America Influenza Vaccines Sales Market Share by Application (2015-2020)
Table 61. Middle East and Africa Influenza Vaccines Sales by Country (2015-2020) (K Units)
Table 62. Middle East and Africa Influenza Vaccines Sales Market Share by Country (2015-2020)
Table 63. Middle East and Africa Influenza Vaccines Revenue by Country (2015-2020) (US$ Million)
Table 64. Middle East and Africa Influenza Vaccines Revenue Market Share by Country (2015-2020)
Table 65. Middle East and Africa Influenza Vaccines Sales by Type (2015-2020) (K Units)
Table 66. Middle East and Africa Influenza Vaccines Sales Market Share by Type (2015-2020)
Table 67. Middle East and Africa Influenza Vaccines Sales by Application (2015-2020) (K Units)
Table 68. Middle East and Africa Influenza Vaccines Sales Market Share by Application (2015-2020)
Table 69. AstraZeneca Corporation Information
Table 70. AstraZeneca Description and Major Businesses
Table 71. AstraZeneca Influenza Vaccines Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 72. AstraZeneca Product
Table 73. AstraZeneca Recent Development
Table 74. CSL Corporation Information
Table 75. CSL Description and Major Businesses
Table 76. CSL Influenza Vaccines Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 77. CSL Product
Table 78. CSL Recent Development
Table 79. GlaxoSmithKline Corporation Information
Table 80. GlaxoSmithKline Description and Major Businesses
Table 81. GlaxoSmithKline Influenza Vaccines Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 82. GlaxoSmithKline Product
Table 83. GlaxoSmithKline Recent Development
Table 84. Sanofi Corporation Information
Table 85. Sanofi Description and Major Businesses
Table 86. Sanofi Influenza Vaccines Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 87. Sanofi Product
Table 88. Sanofi Recent Development
Table 89. Altimmune Corporation Information
Table 90. Altimmune Description and Major Businesses
Table 91. Altimmune Influenza Vaccines Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 92. Altimmune Product
Table 93. Altimmune Recent Development
Table 94. BionVax Corporation Information
Table 95. BionVax Description and Major Businesses
Table 96. BionVax Influenza Vaccines Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 97. BionVax Product
Table 98. BionVax Recent Development
Table 99. FluGen Corporation Information
Table 100. FluGen Description and Major Businesses
Table 101. FluGen Influenza Vaccines Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 102. FluGen Product
Table 103. FluGen Recent Development
Table 104. FOLIA BIOTECH Corporation Information
Table 105. FOLIA BIOTECH Description and Major Businesses
Table 106. FOLIA BIOTECH Influenza Vaccines Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 107. FOLIA BIOTECH Product
Table 108. FOLIA BIOTECH Recent Development
Table 109. Genentech Corporation Information
Table 110. Genentech Description and Major Businesses
Table 111. Genentech Influenza Vaccines Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 112. Genentech Product
Table 113. Genentech Recent Development
Table 114. Green Cross Corporation Information
Table 115. Green Cross Description and Major Businesses
Table 116. Green Cross Influenza Vaccines Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 117. Green Cross Product
Table 118. Green Cross Recent Development
Table 119. Medicago Corporation Information
Table 120. Medicago Description and Major Businesses
Table 121. Medicago Influenza Vaccines Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 122. Medicago Product
Table 123. Medicago Recent Development
Table 124. Moderna Therapeutics Corporation Information
Table 125. Moderna Therapeutics Description and Major Businesses
Table 126. Moderna Therapeutics Influenza Vaccines Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 127. Moderna Therapeutics Product
Table 128. Moderna Therapeutics Recent Development
Table 129. Novavax Corporation Information
Table 130. Novavax Description and Major Businesses
Table 131. Novavax Influenza Vaccines Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 132. Novavax Product
Table 133. Novavax Recent Development
Table 134. Shijiazhuang Yiling Pharmaceutical Corporation Information
Table 135. Shijiazhuang Yiling Pharmaceutical Description and Major Businesses
Table 136. Shijiazhuang Yiling Pharmaceutical Influenza Vaccines Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 137. Shijiazhuang Yiling Pharmaceutical Product
Table 138. Shijiazhuang Yiling Pharmaceutical Recent Development
Table 139. SK Chemicals Corporation Information
Table 140. SK Chemicals Description and Major Businesses
Table 141. SK Chemicals Influenza Vaccines Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 142. SK Chemicals Product
Table 143. SK Chemicals Recent Development
Table 144. UNM Pharma Corporation Information
Table 145. UNM Pharma Description and Major Businesses
Table 146. UNM Pharma Influenza Vaccines Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 147. UNM Pharma Product
Table 148. UNM Pharma Recent Development
Table 149. Vaccitech Corporation Information
Table 150. Vaccitech Description and Major Businesses
Table 151. Vaccitech Influenza Vaccines Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 152. Vaccitech Product
Table 153. Vaccitech Recent Development
Table 154. Vaxart Corporation Information
Table 155. Vaxart Description and Major Businesses
Table 156. Vaxart Influenza Vaccines Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 157. Vaxart Product
Table 158. Vaxart Recent Development
Table 159. Vaxine Pty Corporation Information
Table 160. Vaxine Pty Description and Major Businesses
Table 161. Vaxine Pty Influenza Vaccines Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 162. Vaxine Pty Product
Table 163. Vaxine Pty Recent Development
Table 164. Visterra Corporation Information
Table 165. Visterra Description and Major Businesses
Table 166. Visterra Influenza Vaccines Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 167. Visterra Product
Table 168. Visterra Recent Development
Table 169. Global Influenza Vaccines Sales Forecast by Regions (2021-2026) (K Units)
Table 170. Global Influenza Vaccines Sales Market Share Forecast by Regions (2021-2026)
Table 171. Global Influenza Vaccines Revenue Forecast by Regions (2021-2026) (US$ Million)
Table 172. Global Influenza Vaccines Revenue Market Share Forecast by Regions (2021-2026)
Table 173. North America: Influenza Vaccines Sales Forecast by Country (2021-2026) (K Units)
Table 174. North America: Influenza Vaccines Revenue Forecast by Country (2021-2026) (US$ Million)
Table 175. Europe: Influenza Vaccines Sales Forecast by Country (2021-2026) (K Units)
Table 176. Europe: Influenza Vaccines Revenue Forecast by Country (2021-2026) (US$ Million)
Table 177. Asia Pacific: Influenza Vaccines Sales Forecast by Region (2021-2026) (K Units)
Table 178. Asia Pacific: Influenza Vaccines Revenue Forecast by Region (2021-2026) (US$ Million)
Table 179. Latin America: Influenza Vaccines Sales Forecast by Country (2021-2026) (K Units)
Table 180. Latin America: Influenza Vaccines Revenue Forecast by Country (2021-2026) (US$ Million)
Table 181. Middle East and Africa: Influenza Vaccines Sales Forecast by Country (2021-2026) (K Units)
Table 182. Middle East and Africa: Influenza Vaccines Revenue Forecast by Country (2021-2026) (US$ Million)
Table 183. Key Opportunities and Drivers: Impact Analysis (2021-2026)
Table 184. Key Challenges
Table 185. Market Risks
Table 186. Main Points Interviewed from Key Influenza Vaccines Players
Table 187. Influenza Vaccines Customers List
Table 188. Influenza Vaccines Distributors List
Table 189. Research Programs/Design for This Report
Table 190. Key Data Information from Secondary Sources
Table 191. Key Data Information from Primary Sources
List of Figures
Figure 1. Influenza Vaccines Product Picture
Figure 2. Global Influenza Vaccines Sales Market Share by Type in 2020 & 2026
Figure 3. Trivalent Flu Vaccines Product Picture
Figure 4. Quadrivalent Flu Vaccines Product Picture
Figure 5. Global Influenza Vaccines Sales Market Share by Application in 2020 & 2026
Figure 6. Adults
Figure 7. Pediatrics
Figure 8. Influenza Vaccines Report Years Considered
Figure 9. Global Influenza Vaccines Market Size 2015-2026 (US$ Million)
Figure 10. Global Influenza Vaccines Sales 2015-2026 (K Units)
Figure 11. Global Influenza Vaccines Market Size Market Share by Region: 2020 Versus 2026
Figure 12. Global Influenza Vaccines Sales Market Share by Region (2015-2020)
Figure 13. Global Influenza Vaccines Sales Market Share by Region in 2019
Figure 14. Global Influenza Vaccines Revenue Market Share by Region (2015-2020)
Figure 15. Global Influenza Vaccines Revenue Market Share by Region in 2019
Figure 16. Global Influenza Vaccines Sales Share by Manufacturer in 2019
Figure 17. The Top 10 and 5 Players Market Share by Influenza Vaccines Revenue in 2019
Figure 18. Influenza Vaccines Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019
Figure 19. Global Influenza Vaccines Sales Market Share by Type (2015-2020)
Figure 20. Global Influenza Vaccines Sales Market Share by Type in 2019
Figure 21. Global Influenza Vaccines Revenue Market Share by Type (2015-2020)
Figure 22. Global Influenza Vaccines Revenue Market Share by Type in 2019
Figure 23. Global Influenza Vaccines Market Share by Price Range (2015-2020)
Figure 24. Global Influenza Vaccines Sales Market Share by Application (2015-2020)
Figure 25. Global Influenza Vaccines Sales Market Share by Application in 2019
Figure 26. Global Influenza Vaccines Revenue Market Share by Application (2015-2020)
Figure 27. Global Influenza Vaccines Revenue Market Share by Application in 2019
Figure 28. North America Influenza Vaccines Sales Growth Rate 2015-2020 (K Units)
Figure 29. North America Influenza Vaccines Revenue Growth Rate 2015-2020 (US$ Million)
Figure 30. North America Influenza Vaccines Sales Market Share by Country in 2019
Figure 31. North America Influenza Vaccines Revenue Market Share by Country in 2019
Figure 32. U.S. Influenza Vaccines Sales Growth Rate (2015-2020) (K Units)
Figure 33. U.S. Influenza Vaccines Revenue Growth Rate (2015-2020) (US$ Million)
Figure 34. Canada Influenza Vaccines Sales Growth Rate (2015-2020) (K Units)
Figure 35. Canada Influenza Vaccines Revenue Growth Rate (2015-2020) (US$ Million)
Figure 36. North America Influenza Vaccines Market Share by Type in 2019
Figure 37. North America Influenza Vaccines Market Share by Application in 2019
Figure 38. Europe Influenza Vaccines Sales Growth Rate 2015-2020 (K Units)
Figure 39. Europe Influenza Vaccines Revenue Growth Rate 2015-2020 (US$ Million)
Figure 40. Europe Influenza Vaccines Sales Market Share by Country in 2019
Figure 41. Europe Influenza Vaccines Revenue Market Share by Country in 2019
Figure 42. Germany Influenza Vaccines Sales Growth Rate (2015-2020) (K Units)
Figure 43. Germany Influenza Vaccines Revenue Growth Rate (2015-2020) (US$ Million)
Figure 44. France Influenza Vaccines Sales Growth Rate (2015-2020) (K Units)
Figure 45. France Influenza Vaccines Revenue Growth Rate (2015-2020) (US$ Million)
Figure 46. U.K. Influenza Vaccines Sales Growth Rate (2015-2020) (K Units)
Figure 47. U.K. Influenza Vaccines Revenue Growth Rate (2015-2020) (US$ Million)
Figure 48. Italy Influenza Vaccines Sales Growth Rate (2015-2020) (K Units)
Figure 49. Italy Influenza Vaccines Revenue Growth Rate (2015-2020) (US$ Million)
Figure 50. Russia Influenza Vaccines Sales Growth Rate (2015-2020) (K Units)
Figure 51. Russia Influenza Vaccines Revenue Growth Rate (2015-2020) (US$ Million)
Figure 52. Europe Influenza Vaccines Market Share by Type in 2019
Figure 53. Europe Influenza Vaccines Market Share by Application in 2019
Figure 54. Asia Pacific Influenza Vaccines Sales Growth Rate 2015-2020 (K Units)
Figure 55. Asia Pacific Influenza Vaccines Revenue Growth Rate 2015-2020 (US$ Million)
Figure 56. Asia Pacific Influenza Vaccines Sales Market Share by Region in 2019
Figure 57. Asia Pacific Influenza Vaccines Revenue Market Share by Region in 2019
Figure 58. China Influenza Vaccines Sales Growth Rate (2015-2020) (K Units)
Figure 59. China Influenza Vaccines Revenue Growth Rate (2015-2020) (US$ Million)
Figure 60. Japan Influenza Vaccines Sales Growth Rate (2015-2020) (K Units)
Figure 61. Japan Influenza Vaccines Revenue Growth Rate (2015-2020) (US$ Million)
Figure 62. South Korea Influenza Vaccines Sales Growth Rate (2015-2020) (K Units)
Figure 63. South Korea Influenza Vaccines Revenue Growth Rate (2015-2020) (US$ Million)
Figure 64. India Influenza Vaccines S

• Clinical Results in Diabetics To Be Boosted By Smart Artificial Beta Cells

For a long time, the cure for diabetes type 1 and type 2 has relied on agonizing insulin shots for patients or insulin infusion via mechanical pumps. Regarding this, experts have been creating artificial pancreatic beta cells with the he…

• High-speed Data Transmission And High Volume Needs Propel Fiber Optic Connectors Market

Fiber optic connectors are a substantial fragment of the global telecommunication industry. Optical fibers are joined using fiber optic connectors, which allow the light conduction between two consecutive optical fibers. An additional im…

• Extensive Use of Digital Technologies for Diagnostic Applications To Boost Global Optical Imaging Market

The global optical imaging system market is predicted to reach US$ 3 billion by 2024. It is expected to grow at a stable rate and will post a CAGR of more than 8% in the coming years. The growing market infiltration of digital …

• Foremost Trends In Global Pet Care Market

The global pet care market is foretold to improve in the forthcoming years as matched to the preceding years and will showcase better sales in various market segments. It is estimated that the global pet care market will grow at a CAGR o…

• China To Review Its Food Security Laws

China has arisen as the globe’s firmest developing economy. In addition, China brags about the biggest population pool in the world. In recent times, the one child policy in the republic was terminated. This is anticipated to upsur…

Global Antioxidant Vitamins Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 100

The global Antioxidant Vitamins market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Antioxidant Vitamins is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Antioxidant Vitamins is estimated to increase from $ million in 2023 to reach $ millio......

Global Clavulanate Potassium Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 86

The global Clavulanate Potassium market was valued at US$ 446.6 million in 2023 and is anticipated to reach US$ 637.2 million by 2030, witnessing a CAGR of 5.2% during The forecast period 2024-2030. North American market for Clavulanate Potassium is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Clavulanate Potassium is estimated to increase from $ million in 2023......

Global Amoxicillin Sodium Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 84

The global Amoxicillin Sodium market was valued at US$ 460.9 million in 2023 and is anticipated to reach US$ 735.1 million by 2030, witnessing a CAGR of 7.0% during The forecast period 2024-2030. North American market for Amoxicillin Sodium is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Amoxicillin Sodium is estimated to increase from $ million in 2023 to reach......

Global Melatonin Supplements Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 106

The global Melatonin Supplements market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Melatonin Supplements is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Melatonin Supplements is estimated to increase from $ million in 2023 to reach $ mil......

Global Sleeping Pills (Prescription Drugs) Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 93

The global Sleeping Pills (Prescription Drugs) market was valued at US$ 1022.3 million in 2023 and is anticipated to reach US$ 1437.8 million by 2030, witnessing a CAGR of 4.9% during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical......

Global Sleeping Pills Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 94

The global Sleeping Pills market was valued at US$ 2042.3 million in 2023 and is anticipated to reach US$ 2979.5 million by 2030, witnessing a CAGR of 3.8% during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estim......

Global Zinc Oral Drops Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 85

The global Zinc Oral Drops market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Zinc Oral Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Zinc Oral Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a......

Global Zinc Drops Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 85

The global Zinc Drops market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Zinc Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Zinc Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % duri......

Global Anti-Infectives Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 78

The global Anti-Infectives market was valued at US$ 22700 million in 2023 and is anticipated to reach US$ 27480 million by 2030, witnessing a CAGR of 2.3% during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estima......

We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s. Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors. Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business. Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision. Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us. Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done. Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )

• Ad Hoc
• Pay - as - you - go / Bucket Subscriptions
• Fixed Cost for #of reports
• Customize / Personalize as per your needs